Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Chenodeoxycholic acid regulatory update

September 26, 2016 7:00 AM UTC

EMA’s CHMP recommended approval of chenodeoxycholic acid from Sigma-Tau to treat cerebrotendinous xanthomatosis. The naturally occurring bile acid is approved as Xenbilox in the EU to treat gall ston...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article